Kanebo Ltd.
www.kanebo.co.jp
Latest From Kanebo Ltd.
Contamination and Raw Material Testing Issues Raised in FDA Warning Letters
FDA investigators are continuing to find contamination problems and inadequate testing, according to 20 warning letters issued in the first half of 2013, as well as a troubling trend of repeat observations at Baxter, Hospira and Apotex. Observers say to expect more sterility concerns in future warning letters, particularly involving mold, as FDA ramps up GMP enforcement at compounding pharmacies.
Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets
As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.
Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets
As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.
Digene's Long Road Towards a Blockbuster
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
Japan
-
Japan
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Kanebo Ltd.
- Senior Management
- Takashi Hoashi, Chmn. & Pres.
- Contact Info
-
Kanebo Ltd.
Phone: (81) 3 5446 3006
17-4, Sumida 5-Chome
Sumida-Ku
Tokyo, 131-0031
Japan
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice